Living kidney donation is associated with a modestly increased risk of gestational hypertension, preeclampsia, or eclampsia. Women who become pregnant after donating a kidney face increased risks of ...

Participants in the treatment group experienced a 93.5% reduction in urine soluble C5b9 levels from baseline to 24 months.

Telitacicept was associated with 6 times the odds of a decrease in proteinuria compared with immunosuppressive treatment at 48 weeks.

Sparsentan lowered blood pressure more than irbesartan at week 8, with mean differences of -7.2 mmHg systolic and -5.6 mmHg diastolic.

A bladder-sparing active surveillance program reported on outcomes in patients with muscle-invasive bladder cancer (MIBC).

Keisha L. Gibson, MD, MPH, is a physician scientist and the division chief of Pediatric Nephrology department at UNC School ...

An investigator reported the results of a prespecified interim analysis of the phase 3 I CAN trial of ravulizumab for immunoglobulin A nephropathy.

The randomized VIDEO-KD trial tested the value of an ESKD video decision aid vs usual care for advanced care planning among older patients with advanced CKD.

Korean patients with CKD may be more susceptible to the risks of excess protein restriction. A dietary protein intake of less than 0.6 g/kg/d does not appear renoprotective, but instead may increase ...

Bodily pain, vitality, and general health perceptions showed stronger associations with quality of life at lower proteinuria thresholds.

Clinically approved drugs induced ChAT expression and acetylcholine production in podocytes in vivo, suggesting the pathway could be pharmacologically targeted.